Peculiarities of studying the effects of pathogen reduction technologies on platelets

Proteomics - Clinical Applications

Volumn 10, Issue 8, 2016, Pages 805-815

  Osman, Abdimajid ^a,b   Hitzler, Walter E ^c   Provost, Patrick ^d,e  

^a Region Östergötland ^*  (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d University Laval   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

Author keywords

MicroRNA; Pathogen reduction; Platelet concentrate; Platelet proteomic; Transfusion medicine

Indexed keywords

GENOMIC DNA; MESSENGER RNA; MICRORNA; NUCLEIC ACID; REACTIVE OXYGEN METABOLITE; THROMBOCYTE CONCENTRATE; TRANSCRIPTOME;

3' UNTRANSLATED REGION; BLEEDING; BLOOD SAFETY; CELL FRACTIONATION; CLINICAL EFFECTIVENESS; CROSS LINKING; DEVICE APPROVAL; DEVICE SAFETY; GAMMA IRRADIATION; HUMAN; IN VITRO STUDY; MEGAKARYOCYTE; MITOCHONDRION; PATHOGEN REDUCTION SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RNA SEQUENCE; RNA SYNTHESIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; ULTRAVIOLET RADIATION;

EID: 84987816355     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201500124     Document Type: Review

References (84)

1. Harker, L. A., Finch, C. A., Thrombokinetics in man. J. Clin. Invest. 1969, 48, 963–974.
2. Hartwig, J. H., The platelet: form and function. Semin. Hematol. 2006, 43S1, S94–S100.
3. Roth, G. J., Hickey, M. J., Chung, D. W., Hickstein, D. D., Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem. Biophys. Res. Commun. 1989, 160, 705–710.
4. Ts'ao, C. H., Rough endoplasmic reticulum and ribosomes in blood platelets. Scand. J. Haematol. 1971, 8, 134–140.
5. Kieffer, N., Guichard, J., Farcet, J. P., Vainchenker, W., Breton-Gorius, J., Biosynthesis of major platelet proteins in human blood platelets. Eur. J. Biochem. / FEBS 1987, 164, 189–195.
6. Booyse, F. M., Rafelson, M. E.,Jr., Studies on human platelets. I. synthesis of platelet protein in a cell-free system. Biochim. Biophys. Acta 1968, 166, 689–697.
7. Weyrich, A. S., Dixon, D. A., Pabla, R., Elstad, M. R. et al., Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 5556–5561.
8. Evangelista, V., Manarini, S., Di Santo, A., Capone, M. L. et al., De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ. Res. 2006, 98, 593–595.
9. Edelstein, L. C., Bray, P. F., MicroRNAs in platelet production and activation. Blood 2011, 117, 5289-5-296.
10. Schubert, P., Devine, D. V., De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang. 2010, 99, 112–122.
11. Thon, J. N., Devine, D. V., Translation of glycoprotein IIIa in stored blood platelets. Transfusion 2007, 47, 2260–2270.
12. Kissopoulou, A., Jonasson, J., Lindahl, T. L., Osman, A., Next generation sequencing analysis of human platelet PolyA+ mRNAs and rRNA-depleted total RNA. PLoS One 2013, 8, e81809.
13. Londin, E. R., Hatzimichael, E., Loher, P., Edelstein, L. et al., The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome. Biol. Direct 2014, 9, 3.
14. Rowley, J. W., Oler, A. J., Tolley, N. D., Hunter, B. N. et al., Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011, 118, e101–111.
15. Bugert, P., Dugrillon, A., Gunaydin, A., Eichler, H., Kluter, H., Messenger RNA profiling of human platelets by microarray hybridization. Thromb. Haemost. 2003, 90, 738–748.
16. Gnatenko, D. V., Dunn, J. J., McCorkle, S. R., Weissmann, D. et al., Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003, 101, 2285–2293.
17. McRedmond, J. P., Park, S. D., Reilly, D. F., Coppinger, J. A. et al., Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol. Cell. Proteomics 2004, 3, 133–144.
18. Schubert, S., Weyrich, A. S., Rowley, J. W., A tour through the transcriptional landscape of platelets. Blood 2014, 124, 493–502.
19. Dittrich, M., Birschmann, I., Pfrang, J., Herterich, S. et al., Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb. Haemost. 2006, 95, 643–651.
20. Lai, E. C., Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 2002, 30, 363–364.
21. Landry, P., Plante, I., Ouellet, D. L., Perron, M. P. et al., Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol. 2009, 16, 961–966.
22. Osman, A., Falker, K., Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 2011, 22, 433–441.
23. Bruchova, H., Merkerova, M., Prchal, J. T., Aberrant expression of microRNA in polycythemia vera. Haematologica 2008, 93, 1009–1016.
24. Nagalla, S., Shaw, C., Kong, X., Kondkar, A. A. et al., Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011, 117, 5189–5197.
25. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., Tuschl, T., Identification of novel genes coding for small expressed RNAs. Science 2001, 294, 853–858.
26. Lau, N. C., Lim, L. P., Weinstein, E. G., Bartel, D. P., An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294, 858–862.
27. Lee, R. C., Ambros, V., An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294, 862–864.
28. Lee, Y., Ahn, C., Han, J., Choi, H. et al., The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425, 415–419.
29. Provost, P., Dishart, D., Doucet, J., Frendewey, D. et al., Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J. 2002, 21, 5864–5874.
30. Pillai, R. S., Bhattacharyya, S. N., Artus, C. G., Zoller, T. et al., Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005, 309, 1573–1576.
31. Bartel, D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009, 136, 215–233.
32. Perron, M. P., Boissonneault, V., Gobeil, L. A., Ouellet, D. L., Provost, P., Regulatory RNAs: future perspectives in diagnosis, prognosis, and individualized therapy. Methods Mol. Biol. 2007, 361, 311–326.
33. Kondkar, A. A., Bray, M. S., Leal, S. M., Nagalla, S. et al., VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J. Thromb. Haemost. 2010, 8, 369–378.
34. Cimmino, G., Tarallo, R., Nassa, G., De Filippo, M. R. et al., Activating stimuli induce platelet microRNA modulation and proteome reorganisation. Thromb. Haemost. 2015, 114, 96–108.
35. Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y. et al., Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 2004, 15, 185–197.
36. Zamore, P. D., Haley, B., Ribo-gnome: the big world of small RNAs. Science 2005, 309, 1519–1524.
37. Kim, V. N., MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 2005, 6, 376–385.
38. Laffont, B., Corduan, A., Ple, H., Duchez, A. C. et al., Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood 2013, 122, 253–261.
39. Laffont, B., Corduan, A., Rousseau, M., Duchez, A. C. et al., Platelet microparticles reprogram macrophage gene expression and function. Thromb. Haemost. 2015, 115, 311–323.
40. Wollowitz, S., Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin. Hematol. 2001, 38, 4–11.
41. Klein, H. G., Anderson, D., Bernardi, M. J., Cable, R. et al., Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007, 47, 2338–2347.
42. Kerkhoffs, J. L., van Putten, W. L., Novotny, V. M., Te Boekhorst, P. A. et al., Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br. J. Haematol. 2010, 150, 209–217.
43. Vamvakas, E. C., Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets. Transfusion 2011, 51, 1058–1071.
44. van Rhenen, D., Gulliksson, H., Cazenave, J. P., Pamphilon, D. et al., Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003, 101, 2426–2433.
45. Snyder, E., McCullough, J., Slichter, S. J., Strauss, R. G. et al., Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 2005, 45, 1864–1875.
46. Janetzko, K., Cazenave, J. P., Kluter, H., Kientz, D. et al., Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. Transfusion 2005, 45, 1443–1452.
47. Mirasol Clinical Evaluation Study, G., A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010, 50, 2362–2375.
48. Group, M. C. E. S., A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010, 50, 2362–2375.
49. Hitzler, W., Vamvakas, E. C., Platelet microRNA profiles and the effect of pathogen reduction on platelet function. Clin. Lab. 2011, 57, 451–454.
50. Apelseth, T. O., Bruserud, O., Wentzel-Larsen, T., Bakken, A. M. et al., In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007, 47, 653–665.
51. Carvalho, H., Alguero, C., Santos, M., de Sousa, G. et al., The combined effect of platelet storage media and intercept pathogen reduction technology on platelet activation/activability and cellular apoptosis/necrosis: Lisbon-RBS experience. Transfus. Apher. Sci. 2006, 34, 187–192.
52. Johnson, L., Loh, Y. S., Kwok, M., Marks, D. C., In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system. Transfus. Med. 2013, 23, 121–129.
53. Perez-Pujol, S., Tonda, R., Lozano, M., Fuste, B. et al., Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 2005, 45, 911–919.
54. Tauszig, M. E., Picker, S. M., Gathof, B. S., Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction. Transfus. Apher. Sci. 2012, 46, 33–37.
55. Osman, A., Hitzler, W. E., Meyer, C. U., Landry, P. et al., Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets 2015, 26, 154–163.
56. Osman, A., Hitzler, W. E., Ameur, A., Provost, P., Differential expression analysis by RNA-Seq reveals perturbations in the platelet mRNA transcriptome triggered by pathogen reduction systems. PLoS One 2015, 10, e0133070.
57. Stivala, S., Gobbato, S., Reiner, M. F., Meyer, S. C. et al., The Intercept blood system affects platelet function and survival by inducing apoptosis. Blood 2014, 124, 4283.
58. Boilard, E., Nigrovic, P. A., Larabee, K., Watts, G. F. et al., Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327, 580–583.
59. Beyer, C., Pisetsky, D. S., The role of microparticles in the pathogenesis of rheumatic diseases. Nat. Rev. Rheumatol. 2010, 6, 21–29.
60. Rautou, P. E., Vion, A. C., Amabile, N., Chironi, G. et al., Microparticles, vascular function, and atherothrombosis. Circ. Res. 2011, 109, 593–606.
61. Boudreau, L. H., Duchez, A. C., Cloutier, N., Soulet, D. et al., Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014, 124, 2173–2183.
62. Vasudevan, S., Tong, Y., Steitz, J. A., Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318, 1931–1934.
63. Truesdell, S. S., Mortensen, R. D., Seo, M., Schroeder, J. C. et al., MicroRNA-mediated mRNA translation activation in quiescent cells and oocytes involves recruitment of a nuclear microRNP. Sci. Rep. 2012, 2, 842.
64. Kriebardis, A., Antonelou, M., Stamoulis, K., Papassideri, I., Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions? Blood Transfus. 2012, 10(Suppl 2), s25–38.
65. Vandromme, M. J., McGwin, G., Jr., Marques, M. B., Kerby, J. D. et al., Transfusion and pneumonia in the trauma intensive care unit: an examination of the temporal relationship. J. Trauma. 2009, 67, 97–101.
66. Koch, C. G., Li, L., Sessler, D. I., Figueroa, P. et al., Duration of red-cell storage and complications after cardiac surgery. N. Engl. J. Med. 2008, 358, 1229–1239.
67. Seghatchian, J., Krailadsiri, P., Current position on preparation and quality of leucodepleted platelet concentrates for clinical use. Transfus. Sci. 2000, 22, 85–88.
68. Prudent, M., D'Alessandro, A., Cazenave, J. P., Devine, D. V. et al., Proteome changes in platelets after pathogen inactivation–an interlaboratory consensus. Transfus. Med. Rev. 2014, 28, 72–83.
69. Walkowiak, B., Kaminska, M., Okroj, W., Tanski, W. et al., The blood platelet proteome is changed in UREMIC patients. Platelets 2007, 18, 386–388.
70. Coppinger, J. A., Cagney, G., Toomey, S., Kislinger, T. et al., Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103, 2096–2104.
71. Garcia, B. A., Smalley, D. M., Cho, H., Shabanowitz, J. et al., The platelet microparticle proteome. J. Proteome Res. 2005, 4, 1516–1521.
72. Piersma, S. R., Broxterman, H. J., Kapci, M., de Haas, R. R. et al., Proteomics of the TRAP-induced platelet releasate. J. Proteomics 2009, 72, 91–109.
73. Schubert, P., Culibrk, B., Coupland, D., Scammell, K. et al., Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage. Transfusion 2012, 52, 397–408.
74. Schubert, P., Coupland, D., Culibrk, B., Goodrich, R. P., Devine, D. V., Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment. Transfusion 2013, 53, 3164–3173.
75. Marrocco, C., D'Alessandro, A., Girelli, G., Zolla, L., Proteomic analysis of platelets treated with gamma irradiation versus a commercial photochemical pathogen reduction technology. Transfusion 2013, 53, 1808–1820.
76. Hechler, B., Ohlmann, P., Chafey, P., Ravanat, C. et al., Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation. Transfusion 2013, 53, 1187–1200.
77. Thiele, T., Sablewski, A., Iuga, C., Bakchoul, T. et al., Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation–a LC-ESI-MS/MS-based proteomics approach. Blood Transfus. 2012, 10(Suppl 2), s63–70.
78. Prudent, M., Crettaz, D., Delobel, J., Tissot, J. D., Lion, N., Proteomic analysis of Intercept-treated platelets. J. Proteomics 2012, 76Spec No., 316–328.
79. Prudent, M., Sonego, G., Abonnenc, M., Tissot, J. D., Lion, N., LC-MS/MS analysis and comparison of oxidative damages on peptides induced by pathogen reduction technologies for platelets. J. Am. Soc. Mass Spectrom. 2014, 25, 651–661.
80. Schubert, P., Karwal, S., Devine, D. V., Dynamics of signal transduction triggered in platelet by riboflavin/UV treatment: relocalization of GTPases enhances platelet function. Transfusion 2012, 52, 19A.
81. Picker, S. M., Current methods for the reduction of blood-borne pathogens: a comprehensive literature review. Blood Transfusion = Trasfusione del sangue 2013, 11, 343–348.
82. Cadet, J., Douki, T., Oxidatively generated damage to DNA by UVA radiation in cells and human skin. J. Invest. Dermatol. 2011, 131, 1005–1007.
83. Marks, D. C., Faddy, H. M., Johnson, L., Pathogen reduction technologies. ISBT Science Series 2014, 9, 44–50.
84. Silliman, C. C., Kelher, M. R., Khan, S. Y., LaSarre, M. et al., Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo. Blood 2014, 123, 3488–3495.